Dan Dearen

Mr. Danny L.
Dearen is an Independent Director at InspireMD, Inc., an Independent Director at Beta Bionics, Inc., an Independent Director at JenaValve Technology, Inc. and an Independent Director at Endotronix, Inc. He is on the Board of Directors at InspireMD, Inc., Beta Bionics, Inc., JenaValve Technology, Inc., Endotronix, Inc. and Allevion Therapeutics, Inc. Mr. Dearen was previously employed as a President, Chief Financial & Accounting Officer by Axonics, Inc., a Chief Financial & Operating Officer by Vessix Vascular, Inc., a Chief Financial Officer by Miraval Holding LLC, a Chief Financial Officer by Quantitative Three-Dimensional Microscopy, Inc., a Chief Financial Officer by Fairbanks Systems Group, a Chief Financial Officer by ESI Software, Inc., a Chief Financial Officer by Medication Delivery Devices, Inc., a Principal by Ventana Growth Fund, a Principal by Ernst & Whinney, and a Chief Financial Officer & Executive Vice President by SkyDesk, Inc. He received his undergraduate degree from Southern Methodist University and an MBA from Boston College.